0001375852-19-000009.txt : 20190626
0001375852-19-000009.hdr.sgml : 20190626
20190626173700
ACCESSION NUMBER: 0001375852-19-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190625
FILED AS OF DATE: 20190626
DATE AS OF CHANGE: 20190626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lamb Scott E
CENTRAL INDEX KEY: 0001375852
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 19922494
MAIL ADDRESS:
STREET 1: ICU MEDICAL, INC.
STREET 2: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2019-06-25
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001375852
Lamb Scott E
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
Chief Financial Officer,
Common Stock
2019-06-25
4
X
0
21675
58.79
A
34984
D
Common Stock
2019-06-25
4
S
0
21675
250.0
D
13309
D
Common Stock
2019-06-26
4
X
0
3325
58.79
A
16634
D
Common Stock
2019-06-26
4
S
0
3325
250.0
D
13309
D
Non-Qualified Stock Option (right to buy)
58.79
2019-06-25
4
X
0
21675
58.79
D
2024-02-24
Common Stock
21675
78325
D
Non-Qualified Stock Option (right to buy)
58.79
2019-06-26
4
X
0
3325
58.79
D
2024-02-24
Common Stock
3325
75000
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 11, 2019.
All shares sold were sold at the exact price disclosed.
Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days.
Transaction is the exercise of a derivative security; see Column 2.
By: Paula Darbyshire, Attorney-In-Fact For: Scott E. Lamb
2019-06-26